NANCY TAYLOR: Open Payments
NPI 1295916765 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 22 payments from 12 companies in 2025. Trend: 2023 $439 · 2024 $518 · 2025 $564
Food & beverage: $484Education: $80
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $131 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Janssen Biotech, Inc. | 4 | $78 |
| PFIZER INC. | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Rigel Pharmaceuticals, Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Exelixis Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
Products named: MONJUVI, KISQALI, ERLEADA, Fabhalta, DARZALEX, LIBTAYO, TAVALISSE, OJJAARA.
Industry payments across AZ — which companies pay providers there.
